Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)
Funding Opportunity PAR-22-027 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) will support pilot, feasibility or exploratory research in 5 priority areas in substance use epidemiology and health services, including: 1) responses to sudden and severe emerging drug issues (e.g. the ability to look into a large and sudden spike in opioid or synthetic cannabinoid use/overdoses in a particular community); 2) responses to emerging marijuana trends and topics related to the shifting policy landscape; 3) responses to unexpected and time-sensitive prescription drug abuse research opportu...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 2, 2021 Category: Research Source Type: funding
Notice of Participation of the National Institute of Allergy and Infectious Diseases (NIAID) in RFA-DA-22-031, HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R01 Clinical Trial Not Allowed)
Notice NOT-AI-21-076 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 1, 2021 Category: Research Source Type: funding
Notice of Participation of the National Institute of Allergy and Infectious Diseases (NIAID) in RFA-DA-22-032, HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R21 Clinical Trial Not Allowed)
Notice NOT-AI-21-077 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 31, 2021 Category: Research Source Type: funding
HEAL Initiative: Interdisciplinary Teams to Elucidate the Mechanisms of Device-Based Pain Relief (RM1 Clinical Trial Optional)
Funding Opportunity RFA-NS-22-016 from the NIH Guide for Grants and Contracts. More than 25 million Americans suffer from daily chronic pain, a highly debilitating medical condition that is complex and difficult to manage. In recent decades, there has been an overreliance in the prescription of opioids for chronic pain despite their poor ability to improve function and high addiction liability. This contributed to a significant and alarming epidemic of opioid overdose deaths and addictions. Innovative scientific solutions to develop alternative pain treatment options are thus critically needed. Through targeted research...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 31, 2021 Category: Research Source Type: funding
Fentanyl and its Analogs: Effects and Consequences for Treatment of Addiction and Overdose (UG3/UH3 Clinical Trial Optional)
Funding Opportunity RFA-DA-22-022 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to support research to understand and respond to new challenges in the treatment of drug addiction and overdose, introduced by the now widespread presence of fentanyl and its analogs (fentanils) in illicit drug supplies. The UG3/UH3 Phased Innovation Awards Cooperative Agreement involves 2 phases. The UG3 is to support a project with specific milestones to be accomplished by the end of the 2-year period. The UH3 is to provide funding for 3 years to a project that successfully completed ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 12, 2021 Category: Research Source Type: funding
Notice of Correction to RFA-DA-22-031 HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R01 Clinical Trial Not Allowed)
Notice NOT-DA-21-066 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 29, 2021 Category: Research Source Type: funding
Notice of Correction to RFA-DA-22-032, HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R21 Clinical Trial Not Allowed).
Notice NOT-DA-21-067 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 28, 2021 Category: Research Source Type: funding
Engaging and Empowering Vulnerable Families and Communities to Prevent Opioid Use Disorder and Overdose
Grants for projects to develop, adapt, and/or evaluate promising evidence-based models of family and community based prevention for opioid use disorder (OUD) and overdose for children and families, especially those at highest risk. Geographic coverage: Nationwide -- Foundation for Opioid Response Efforts (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - July 26, 2021 Category: American Health Source Type: funding
California Overdose Prevention Network Accelerator 3.0 Program
A 12-month training, coaching, and networking program for coalitions in California to develop and expand strategies to address overdose rates from fentanyl, methamphetamines, and other drugs. Coalitions from rural areas and other overdose "hot spots" are encouraged to apply. Geographic coverage: California -- California Overdose Prevention Network (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - July 26, 2021 Category: American Health Source Type: funding
HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-DA-22-031 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support research projects focusing on the identification of druggable new targets and discovery of optimizable probes for development of safe and efficacious medications to prevent and treat opioid use disorders (OUDs), opioid overdose, and opioid-polysubstance use comorbidities. This FOA is part of the NIH Helping to End Addictions Long-term (HEAL) initiative to accelerate the development of novel medications to treat all aspects of the opioid addiction cycle, including progres...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 6, 2021 Category: Research Source Type: funding
HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R21 Clinical Trial Not Allowed)
Funding Opportunity RFA-DA-22-032 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support research projects focusing on the identification of druggable new targets and discovery of optimizable probes for development of safe and efficacious medications to prevent and treat opioid use disorders (OUDs), opioid overdose, and opioid-polysubstance use comorbidities. This FOA is part of the NIH Helping to End Addictions Long-term (HEAL) initiative to accelerate the development of novel medications to treat all aspects of the opioid addiction cycle, including progres...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 6, 2021 Category: Research Source Type: funding
Opioid Crisis Innovation Challenge 2021
Grants for innovative, multi-disciplinary projects to address the opioid crisis reducing overdoses, increasing access to treatment, and supporting long-term recovery. Projects should focus on vulnerable populations, which includes rural communities. Geographic coverage: Nationwide -- Foundation for Opioid Response Efforts (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - May 20, 2021 Category: American Health Source Type: funding
Maryland COVID-19 and Overdose Response Grants Initiative
Funding to enhance or initiate projects in Maryland that address harms related to the COVID-19 pandemic among people who use drugs. The overall program goal is to reduce substance-related morbidity and mortality by optimizing services for people who use drugs by improving access to service entry points, leveraging non-traditional service delivery models, increasing the capacity and harm reduction competence of the healthcare workforce, and ensuring systems are responsive to local needs. Geographic coverage: Maryland -- Maryland Department of Health (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - May 12, 2021 Category: American Health Source Type: funding
California MAT Access Points Project: Stimulant Use Prevention and Treatment in Communities of Color
Grants for prevention and treatment programs in California that address stimulant use in communities of color, with focus on Black, American Indian and Alaska Native, and Hispanic/Latino communities that have experienced substantial stimulant related overdose deaths. Geographic coverage: California -- The Center at Sierra Health Foundation (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - April 13, 2021 Category: American Health Source Type: funding
Grants to Prevent Prescription Drug/Opioid Overdose-Related Deaths
Provides funding to states, U.S. territories, and the Red Lake Band of Chippewa that receive the Substance Abuse Prevention and Treatment Block Grant to reduce the number of prescription drug and opioid overdose-related deaths and adverse events among individuals 18 years of age and older. Geographic coverage: Nationwide -- Substance Abuse and Mental Health Services Administration, U.S. Department of Health and Human Services (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - January 6, 2021 Category: American Health Source Type: funding
